Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to pr...
Summary: The plasticity of a preexisting regulatory circuit compromises the effectiveness of targete...
Our understanding of cancer has recently seen a major paradigm shift resulting in it being viewed as...
Cancer is a multigenic disease. The genetic distinctness of cancer cells offers a weakness that can ...
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of ...
Synthetic dosage lethality (SDL) denotes a genetic interaction between two genes whereby the underex...
The interest in studying metabolic alterations in cancer and their potential role as novel targets f...
Background: Synthetic lethality (SL) refers to the genetic interaction between two or more genes whe...
Abstract Exploiting synthetic lethality is a promising strategy for developing targeted cancer thera...
Metabolism plays a crucial role in cellular behaviors and activities. The abnormal metabolism has be...
A promising strategy for finding new cancer drugs is to use metabolic network models to investigate ...
Cancer is a leading cause of death in the world, and the mechanisms underlying this disease are stil...
Synthetic lethality occurs when the inhibition of two genes is lethal while the inhibition of each s...
peer reviewedMetabolism is considered to be the core of all cellular activity. Thus, extensive studi...
Cancer is a leading cause of death in the world, and the mechanisms that underlie this disease are s...
Metabolic reprogramming plays an important role in cancer development and progression and is a well-...
Summary: The plasticity of a preexisting regulatory circuit compromises the effectiveness of targete...
Our understanding of cancer has recently seen a major paradigm shift resulting in it being viewed as...
Cancer is a multigenic disease. The genetic distinctness of cancer cells offers a weakness that can ...
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of ...
Synthetic dosage lethality (SDL) denotes a genetic interaction between two genes whereby the underex...
The interest in studying metabolic alterations in cancer and their potential role as novel targets f...
Background: Synthetic lethality (SL) refers to the genetic interaction between two or more genes whe...
Abstract Exploiting synthetic lethality is a promising strategy for developing targeted cancer thera...
Metabolism plays a crucial role in cellular behaviors and activities. The abnormal metabolism has be...
A promising strategy for finding new cancer drugs is to use metabolic network models to investigate ...
Cancer is a leading cause of death in the world, and the mechanisms underlying this disease are stil...
Synthetic lethality occurs when the inhibition of two genes is lethal while the inhibition of each s...
peer reviewedMetabolism is considered to be the core of all cellular activity. Thus, extensive studi...
Cancer is a leading cause of death in the world, and the mechanisms that underlie this disease are s...
Metabolic reprogramming plays an important role in cancer development and progression and is a well-...
Summary: The plasticity of a preexisting regulatory circuit compromises the effectiveness of targete...
Our understanding of cancer has recently seen a major paradigm shift resulting in it being viewed as...
Cancer is a multigenic disease. The genetic distinctness of cancer cells offers a weakness that can ...